Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Homo sapiens | K(lysine) acetyltransferase 2A | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0178 | 0.5 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.0051 | 0.0402 | 1 |
Brugia malayi | hypothetical protein | 0.003 | 0.0178 | 0.0115 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0178 | 0.5 |
Plasmodium falciparum | histone acetyltransferase GCN5 | 0.0047 | 0.0357 | 1 |
Loa Loa (eye worm) | camk/mapkapk/mapkapk protein kinase | 0.0954 | 1 | 1 |
Brugia malayi | acetyltransferase, GNAT family protein | 0.0175 | 0.1716 | 0.1663 |
Plasmodium vivax | histone acetyltransferase GCN5, putative | 0.0051 | 0.0402 | 1 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.0175 | 0.1716 | 0.1716 |
Loa Loa (eye worm) | acetyltransferase | 0.0175 | 0.1716 | 0.1565 |
Echinococcus granulosus | MAP kinase activated protein kinase 2 | 0.0954 | 1 | 1 |
Echinococcus multilocularis | MAP kinase activated protein kinase 2 | 0.0954 | 1 | 1 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.0051 | 0.0402 | 1 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0051 | 0.0402 | 0.0402 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.0047 | 0.0357 | 0.5 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0051 | 0.0402 | 0.5 |
Trichomonas vaginalis | cat eye syndrome critical region protein 2, cscr2, putative | 0.0051 | 0.0402 | 0.5 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.003 | 0.0178 | 0.5 |
Entamoeba histolytica | acetyltransferase, GNAT family | 0.0047 | 0.0357 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0954 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.003 | 0.0178 | 0.5 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.0175 | 0.1716 | 0.1716 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.017 | 0.1664 | 0.1664 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.0015 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 0.631 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase. (Class of assay: confirmatory) [Related pubchem assays: 1379 ] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.